An Electronic Shared Decision-Making Application to Improve Asthma Outcomes
1 other identifier
interventional
81
1 country
1
Brief Summary
This study will increase knowledge about the feasibility and effect on patient satisfaction and clinical outcomes of using an electronic Shared Decision Making (SDM) application (app) for patients with asthma in the allergy/immunology clinic visit setting. SDM is defined as an approach where clinicians and patients share the best available evidence when faced with the task of making decisions, and where patients are supported to consider options and make informed choices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable asthma
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 3, 2021
CompletedFirst Submitted
Initial submission to the registry
June 4, 2021
CompletedFirst Posted
Study publicly available on registry
July 6, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 14, 2022
CompletedNovember 17, 2022
November 1, 2022
1.1 years
June 4, 2021
November 16, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient satisfaction
Patient satisfaction as determined by Patient Satisfaction Questionnaire responses. Questions will consist of the SDM-Q-9 (psychometrically validated measures for shared decision-making from the perspectives of patients), questions regarding satisfaction with content covered during the visit, and questions regarding satisfaction with the overall communication between the patient and physician.
Within 1 week of completing asthma shared decision making app worksheet and their asthma clinic visit
Secondary Outcomes (2)
Physician satisfaction
Within 1 week of patient visit
Change in level of asthma control will be determined
Up to 6 months
Study Arms (4)
Group A Patients who receive SDM intervention
EXPERIMENTALGroup A patients will complete a pre-visit electronic Asthma SDM App. They may also receive educational information regarding asthma, medication management, smoking cessation, COVID-19 and COVID-19 vaccines.
Group B Patients who receive standard care
ACTIVE COMPARATORGroup B patients will receive standard care.
Group A Physicians who receive SDM training and electronic Asthma SDM App data
EXPERIMENTALGroup A physicians will view an SDM Physician Training Video and receive the patients' reported data from the pre-visit asthma SDM App prior to the patients' visits.
Group B Physicians who provide standard care
ACTIVE COMPARATORGroup B physicians will provide standard care.
Interventions
The electronic Asthma SDM App will ask questions related to medicine-related, non-medicine-related, and COVID-19-related concerns about patients' asthma, the patients' personal goals for asthma control and expectation for their upcoming visit, and the patients' preferred level of details and involvement in coming to a decision about their asthma treatment. They may also use the Asthma SDM app to find information about asthma, medication management, COVID-19 and COVID-19 vaccines.
Training video to educate physicians on Shared Decision-Making and the use of Shared Decision-Making tools.
Data from the pre-visit electronic Asthma SDM app completed by the patients. Data includes medicine-related, non-medicine-related, and COVID-related concerns about patients' asthma, the patients' personal goals for asthma control and expectation for their upcoming visit, and the patients' preferred level of details and involvement in coming to a decision about their asthma treatment.
Standard Care for asthma.
Eligibility Criteria
You may qualify if:
- English speaking
- Diagnosis of persistent asthma
- Have an in-person visit or telehealth encounter at the allergy/clinical immunology clinics participating in this study
You may not qualify if:
- Diagnosis of intermittent asthma
- Any other lung disease
- Smoking greater than 20 pack years or current smoking
- Mental impairment such that participation would not be possible
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Michigan Medicine, University of Michigan
Ann Arbor, Michigan, 48109, United States
Related Publications (1)
Lee DL, Hammond JW, Finkel K, Gardner DD, Nelson B, Baptist AP. An Electronic Shared Decision-Making App to Improve Asthma Outcomes: A Randomized Controlled Trial. J Allergy Clin Immunol Pract. 2023 Oct;11(10):3116-3122.e5. doi: 10.1016/j.jaip.2023.06.016. Epub 2023 Jun 16.
PMID: 37329951DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alan Baptist, MD
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Internal Medicine
Study Record Dates
First Submitted
June 4, 2021
First Posted
July 6, 2021
Study Start
March 3, 2021
Primary Completion
March 28, 2022
Study Completion
September 14, 2022
Last Updated
November 17, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share